{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:00:10Z","timestamp":1785276010136,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T00:00:00Z","timestamp":1478822400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00784-016-2004-z","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T03:42:27Z","timestamp":1478835747000},"page":"2165-2172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8240-3441","authenticated-orcid":false,"given":"Takuya","family":"Asaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,11]]},"reference":[{"key":"2004_CR1","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72:1938","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"2004_CR2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65(3):415\u2013423","journal-title":"J Oral Maxillofac Surg"},{"issue":"11","key":"2004_CR3","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/j.joms.2011.03.051","volume":"69","author":"M Urade","year":"2011","unstructured":"Urade M, Tanaka N, Furusawa K et al (2011) Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan. J Oral Maxillofac Surg 69(11):e364\u2013e371","journal-title":"J Oral Maxillofac Surg"},{"issue":"12","key":"2004_CR4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.5794\/jjoms.57.658","volume":"57","author":"Y Yamazaki","year":"2011","unstructured":"Yamazaki Y, Sato J, Kitagawa Y et al (2011) A retrospective study of the healing process after tooth extraction in patients receiving oral bisphosphonates for more than 3 years. (Japanese manuscript with English abstracts). Jpn J Oral Maxillofac Surg 57(12):658\u2013665","journal-title":"Jpn J Oral Maxillofac Surg"},{"issue":"9","key":"2004_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.5794\/jjoms.60.514","volume":"60","author":"Y Yamazaki","year":"2014","unstructured":"Yamazaki Y, Sato J, Kitagawa Y et al (2014) A retrospective study of the healing process after tooth extraction in patients receiving oral bisphosphonates. (Japanese manuscript with English abstracts). Jpn J Oral Maxillofac Surg 60(9):514\u2013521","journal-title":"Jpn J Oral Maxillofac Surg"},{"key":"2004_CR6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S1079-2104(98)90029-4","volume":"85","author":"RE Marx","year":"2009","unstructured":"Marx RE, Carlson ER, Eichstaedt RM (2009) Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:638\u2013646","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"2004_CR7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2014.10.015","volume":"51","author":"M Del Fabbro","year":"2015","unstructured":"Del Fabbro M, Gallesio G, Mozzati M (2015) Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. Eur J Cancer 51(1):62\u201374","journal-title":"Eur J Cancer"},{"key":"2004_CR8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","volume":"27","author":"EDM Dohan","year":"1998","unstructured":"Dohan EDM, Rasmusson L, Albrektsson Y (1998) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27:158\u2013167","journal-title":"Trends Biotechnol"},{"key":"2004_CR9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2106\/JBJS.K.00430","volume":"94","author":"AD Mazzocca","year":"2012","unstructured":"Mazzocca AD, McCarthy MBR, Chowaniec DM et al (2012) Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 94:308\u2013316","journal-title":"J Bone Joint Surg Am"},{"key":"2004_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2011.07.004","volume":"157","author":"E Anitua","year":"2012","unstructured":"Anitua E, Alkhraisat MH, Orive G (2012) Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release 157:29\u201338","journal-title":"J Control Release"},{"issue":"2","key":"2004_CR11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.joms.2013.07.027","volume":"72","author":"SS Soydan","year":"2014","unstructured":"Soydan SS, Uckan S (2014) Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: technical report. J Oral Maxillofac Surg 72(2):322\u2013326","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"2004_CR12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.oraloncology.2012.03.009","volume":"48","author":"M Mozzati","year":"2012","unstructured":"Mozzati M, Arata V, Gallesio G (2012b) Tooth extraction in patients on zoledronic acid therapy. Oral Oncol 48(9):817\u2013821","journal-title":"Oral Oncol"},{"issue":"9","key":"2004_CR13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","volume":"52","author":"JW Kim","year":"2014","unstructured":"Kim JW, Kim SJ, Kim MR (2014) Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study. Br J Oral Maxillofac Surg 52(9):854\u2013859","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"5","key":"2004_CR14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","volume":"66","author":"R Landesberg","year":"2008","unstructured":"Landesberg R, Cozin M, Cremers S et al (2008) Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 66(5):839\u2013847","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"2004_CR15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","volume":"48","author":"M Mozzati","year":"2012","unstructured":"Mozzati M, Gallesio G, Arata V et al (2012a) Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol 48(5):469\u2013474","journal-title":"Oral Oncol"},{"issue":"4","key":"2004_CR16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00774-009-0047-9","volume":"27","author":"S Cetiner","year":"2009","unstructured":"Cetiner S, Sucak GT, Kahraman SA et al (2009) Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab 27(4):435\u2013443","journal-title":"J Bone Miner Metab"},{"issue":"9","key":"2004_CR17","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.joms.2011.02.078","volume":"69","author":"MM Curi","year":"2011","unstructured":"Curi MM, Cossolin GS, Koga DH et al (2011) Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. J Oral Maxillofac Surg 69(9):2465\u20132472","journal-title":"J Oral Maxillofac Surg"},{"key":"2004_CR18","doi-asserted-by":"crossref","first-page":"298945","DOI":"10.1155\/2014\/298945","volume":"2014","author":"F Longo","year":"2014","unstructured":"Longo F, Guida A, Aversa C et al (2014) Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. Int J Dent 2014:298945","journal-title":"Int J Dent"},{"issue":"11","key":"2004_CR19","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ijom.2012.04.020","volume":"41","author":"S Bocanegra-P\u00e9rez","year":"2012","unstructured":"Bocanegra-P\u00e9rez S, Vicente-Barrero M, Knezevic M et al (2012) Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw. Int J Oral Maxillofac Surg 41(11):1410\u20131415","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2004_CR20","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.tripleo.2005.07.009","volume":"101","author":"DM Dohan","year":"2006","unstructured":"Dohan DM, Choukroun J, Diss A et al (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate\u2014part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:e45\u2013e50","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2004_CR21","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.tripleo.2005.07.011","volume":"101","author":"J Choukroun","year":"2006","unstructured":"Choukroun J, Diss A, Simonpieri A et al (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:e56\u2013e60","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"8","key":"2004_CR22","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/j.jcms.2013.01.018","volume":"41","author":"P Pripatnanont","year":"2013","unstructured":"Pripatnanont P, Nuntanaranont T, Vongvatcharanon S et al (2013) The primacy of platelet-rich fibrin on bone regeneration of various grafts in rabbit\u2019s calvarial defects. I J Craniomaxillofac Surg 41(8):e191\u2013e200","journal-title":"I J Craniomaxillofac Surg"},{"issue":"1","key":"2004_CR23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08977190802636713","volume":"27","author":"DM Dohan Ehrenfest","year":"2009","unstructured":"Dohan Ehrenfest DM, de Peppo GM, Doglioli P et al (2009) Slow release of growth factors and thrombospondin-1 in Choukroun\u2019s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 27(1):63\u201369","journal-title":"Growth Factors"},{"issue":"5","key":"2004_CR24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.tripleo.2009.06.044","volume":"108","author":"L He","year":"2009","unstructured":"He L, Lin Y, Hu X et al (2009) A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108(5):707\u2013713","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"2004_CR25","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00198-012-2239-8","volume":"24","author":"M Mozzati","year":"2013","unstructured":"Mozzati M, Arata V, Gallesio G (2013) Tooth extraction in osteoporotic patients taking oral bisphosphonates. Osteoporos Int 24(5):1707\u20131712","journal-title":"Osteoporos Int"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-016-2004-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-2004-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-2004-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T01:06:00Z","timestamp":1502845560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-016-2004-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,11]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["2004"],"URL":"https:\/\/doi.org\/10.1007\/s00784-016-2004-z","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,11]]}}}